Abstract:Tumor behavior is not entirely determined by tumor cells. Studies have demonstrated that a variety of non-tumor cells in the tumor microenvironment affect tumor behavior; thus, a new focus of cancer research has been the development of novel cancer treatment ideas and therapeutic targets based on the effects of these cells. Mesenchymal stem cells (MSCs) are an important component of the tumor microenvironment; however, previous studies have produced controversial results regarding whether MSCs promote or inhibit tumor growth and progression. In particular, Naïve MSCs and tumor-derived MSCs (T-MSCs) have different functions. Naïve MSCs could exert bidirectional effects on tumors because these cells can both promote and inhibit tumor progression while T-MSCs promote tumor progression due to influences from the tumor itself and from the inflammatory tumor microenvironment. As an unhealed wound, tumor produces a continuous source of inflammatory mediators and causes aggregation of numerous inflammatory cells, which constitute an inflammatory microenvironment. Inflammatory factors can induce homing of circulating MSCs and MSCs in adjacent tissues into tumors, which are then being “educated” by the tumor microenvironment to support tumor growth. T-MSCs could recruit more immune cells into the tumor microenvironment, increase the proportion of cancer stem cells and promote tumor angiogenesis, further supporting tumor progression. However, as plasti city is a fundamental feature of MSCs, MSCs can also inhibit tumors by activating various MSC-based signaling pathways. Studies of the mechanisms by which interactions among tumors, MSCs, and the inflammatory microenvironment occur and methods to disrupt these interactions will likely reveal new targets for cancer therapy.

Mesenchymal Stem/Stromal cells in solid tumor Microenvironment: Orchestrating NK cell remodeling and therapeutic insights

Human-derived Normal Mesenchymal Stem/stromal Cells in Anticancer Therapies

Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets

Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications.

Programming of the Development of Tumor-Promoting Neutrophils by Mesenchymal Stromal Cells

Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity

Mesenchymal Stem/stromal Cells in Cancer Therapy

Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity.

Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy

Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines

Mesenchymal Stem/Stromal Cells in Cancer: from Initiation to Metastasis

Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression

Mesenchymal stem/stromal cells: dedicator to maintain tumor homeostasis

One Cell, Multiple Roles: Contribution of Mesenchymal Stem Cells to Tumor Development in Tumor Microenvironment

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy

Neutrophils in the Tumor Microenvironment and Their Functional Modulation by Mesenchymal Stromal Cells

The roles of mesenchymal stem cells in tumor inflammatory microenvironment

Mesenchymal Stem Cells in Cancer: a New Link to Neutrophils

Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment

The Relationship between Mesenchymal Stem Cells and Tumor

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies